Automated Nucleic Acid Extraction Market To Reach $8.77 Billion By 2033

Automated Nucleic Acid Extraction Market Growth & Trends

The global automated nucleic acid extraction market size is projected to reach USD 8.77 billion by 2033, growing at a CAGR of 11.89% from 2025 to 2033, according to a new report by Grand View Research, Inc. The market is expanding rapidly, with its growth mainly driven by the surge in demand for superior, contamination-free DNA and RNA that are essential for advanced molecular biology, diagnostics, and other medical industry applications, such as biomanufacturing and precision medicine.

The growing acceptance of automation in genomics and other fields, such as biopharmaceuticals, clinical testing, and point-of-care applications, is the reason behind the massive transformation, where manually extracted materials are being replaced by standardized, high-throughput automated ones. The use of next-generation sequencing, cell and gene therapy workflows, and mRNA-based therapeutics has continued to grow. Thus, the need for reliable, scalable, and fast nucleic acid purification systems that can deliver consistent output with minimal hands-on time remains ongoing.

Real-time process monitoring, AI-based optimization, and integration of digital lab platforms are yielding improved traceability, workflow efficiency, and scale-up capabilities in both research and regulated manufacturing environments.

Automated nucleic acid extraction systems will continue to be crucial in ensuring that laboratories worldwide can prepare large-volume, high-quality samples in a clean manner, thereby remaining at the core of the global life sciences and healthcare community.

 Request a free sample copy or view report summary: Automated Nucleic Acid Extraction Market Report

Automated Nucleic Acid Extraction Market Report Highlights

• By product, reagents & consumables accounted for the largest market share of 68.32% in 2024. As laboratories scale molecular testing and adopt automation, consistent consumption of specialized reagents and consumables continues to fuel segment growth, supported by advancements in chemistry, stability, and workflow efficiency.

• By technology, magnetic bead-based extraction systems held the leading share of 52.87% in 2024. Growing utilization in genomics research, clinical diagnostics, biomanufacturing, and cell & gene therapy workflows, along with improved bead chemistry and closed-cartridge formats, further strengthens its market leadership.

• By application, DNA extraction dominated the market in 2024 with a share of 64.94%. The rising adoption of next-generation sequencing, PCR testing, and genomic screening across the healthcare, research, and biotechnology sectors has accelerated demand for rapid and reliable DNA extraction technologies.

• By end use, hospitals and diagnostic centers captured the largest share of 32.41% in 2024. High testing volumes, regulatory compliance needs, and investments in automation to improve turnaround times and accuracy reinforce their market leadership, supported by the expansion of point-of-care molecular systems and centralized laboratory networks.

Automated Nucleic Acid Extraction Market Segmentation

Grand View Research has segmented the global automated nucleic acid extraction market on the basis of product, technology, application, end use, and region.

Automated Nucleic Acid Extraction Product Outlook (Revenue, USD Million, 2021 - 2033)

• Instruments

• Reagents & Consumables

Automated Nucleic Acid Extraction Technology Outlook (Revenue, USD Million, 2021 - 2033)

• Magnetic Bead-based

• Column-based

• Others

Automated Nucleic Acid Extraction Application Outlook (Revenue, USD Million, 2021 - 2033)

• DNA Extraction

• Genomic DNA Extraction

• Plasmid DNA Extraction

• Others

• RNA Extraction

• mRNA Extraction

• miRNA Extraction

• Total RNA Extraction

• Others

Automated Nucleic Acid Extraction End Use Outlook (Revenue, USD Million, 2021 - 2033)

• Academic & Research Institutes

• Pharmaceutical & Biotechnology Companies

• Contract Research Organizations

• Hospitals and Diagnostic Centers

• Others

Automated Nucleic Acid Extraction Regional Outlook (Revenue, USD Million, 2021 - 2033)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • Germany

  • UK

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • China

  • Japan

  • India

  • South Korea

  • Australia

  • Thailand

• Latin America

  • Brazil

  • Argentina

• Middle East & Africa

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players in the Automated Nucleic Acid Extraction Market

• Thermo Fisher Scientific, Inc.

• QIAGEN

• Merck KGaA

• F. Hoffmann-La Roche AG

• Agilent Technologies

• Revvity, Inc.

• Promega Corporation

• Bio?Rad Laboratories

• Takara Bio

• Zymo Research Corporation